Maintenance treatment of preterm labor with the oxytocin antagonist atosiban

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 5, 2000, Pages 1184-1190

  Valenzuela, Guillermo J ^{a,b,c,d,e,f,g,h,i}   Sanchez Ramos, Luis ^{a,b,c,d,e,f,g,h,i}   Romero, Roberto ^{a,b,c,d,e,f,g,h,i}   Silver, Helayne M ^{a,b,c,d,e,f,g,h,i}   Koltun, William D ^{a,b,c,d,e,f,g,h,i}   Millar, Lynnae ^{a,b,c,d,e,f,g,h,i}   Hobbins, John ^{a,b,c,d,e,f,g,h,i}   Rayburn, William ^{a,b,c,d,e,f,g,h,i}   Shangold, Gary ^{a,b,c,d,e,f,g,h,i}   Wang, Julianne ^{a,b,c,d,e,f,g,h,i}   Smith, Judith ^{a,b,c,d,e,f,g,h,i}   Creasy, George W ^{a,b,c,d,e,f,g,h,i}  

^a ARROWHEAD REGIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

^c HUTZEL HOSPITAL   (United States)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF COLORADO HOSPITAL   (United States)

^f UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF HAWAII   (United States)

ⁱ R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

Atosiban; Oxytocin antagonist; Prematurity; Preterm labor; Tocolysis

Indexed keywords

ANTOCIN; ATOSIBAN; OXYTOCIN ANTAGONIST; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HUMAN; MAINTENANCE THERAPY; MULTICENTER STUDY; NEWBORN DEATH; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOCOLYSIS; TREATMENT OUTCOME;

EID: 0034120112     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.105816     Document Type: Article

References (22)

1. 1. Report of the Consensus Development Conference on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Bethesda (MD): National Institutes of Health; 1994 Nov. NIH Publication No. 95-3784.
2. 2. Escobedo MB. Follow-up of prematurely born infants. Clin Obstet Gynecol 1988;31:662-70.
3. 3. King JF, Grant AM, Keirse MJNC, Chalmers I. Beta-mimetics in preterm labour: an overview of randomized controlled trials. Br J Obstet Gynaecol 1988;95:211-22.
4. 4. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992;327:308-12.
5. 5. Higby K, Xenakis E-MJ, Pauerstein CJ. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993;168:1247-59.
6. 6. Kosasa TS, Busse R, Wahl N, Hirata G, Nakayama RT, Hale RW. Long-term tocolysis with combined intravenous terbutaline and magnesium sulfate: a 10-year study of 1000 patients. Obstet Gynecol 1994;84:369-73.
7. 7. Brown S, Tejani N. Terbutaline sulfate in the prevention of recurrence of premature labor. Obstet Gynecol 1981;57:22-4.
8. 8. Creasy RK, Globus M, Laros R, Pareer J, Roberts J. Oral ritodrine maintenance in the treatment of preterm labor. Am J Obstet Gynecol 1980;137:212-6.
9. 9. Holleboom CAG, Merkus JMWM, van Elferen LWM, Keirse MJNC. Double-blind evaluation of ritodrine sustained release of oral maintenance of tocolysis after active preterm labour. Br J Obstet Gynaecol 1996;103:702-5.
10. 10. Zingg H, Lefevre D, Giaid A. Uterine oxytocin gene expression: a novel framework for oxytocin action. Regul Pept 1993;45:13-6.
11. 11. Fuchs AR, Fuchs F, Husslein P, Soloff MS. Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 1984;150:734-41.
12. 12. Soloff M, Fuchs AR, Fuchs F. Oxytocin receptors and the onset of parturition. Perinat Endocrinol 1985;289-311.
13. 13. Goodwin TM, Paul R, Silver H, Spellacy W, Parsons M, Chez R, et al. The effect of the oxytocin antagonist atosiban on preterm uterine artivity in the human. Am J Obstet Gynecol 1994;170:474-8.
14. 14. Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille J-C, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000;182:1173-83.
15. 15. Schoenfeld D. The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika 1981;68:316-9.
16. 16. How HY, Hughes SA, Vogel RL, Gall SA, Spinnato JA. Oral terbutaline in the outpatient management of preterm labor. Am J Obstet Gynecol 1995;173:1518-22.
17. 17. Ricci J, Hariharan S, Helfgott A, Reed K, O'Sullivan MJ. Oral tocolysis with magnesium chloride: a randomized controlled prospective clinical trial. Am J Obstet Gynecol 1991;165:603-10.
18. 18. Rust OA, Bofill JA, Arriola RM, Andrew ME, Morrison JC. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 1996;175:838-42.
19. 19. Parilla B, Dooley S, Minogue J, Socol M. The efficacy of oral terbutaline after intravenous tocolysis. Am J Obstet Gynecol 1983;169:965-9.
20. 20. Lewis R, Mercer BM, Salama M, Walsh MA, Sibai BM. Oral terbutaline after parenteral tocolysis: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 1996;175:834-7.
21. 21. Moutquin J-M, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 2000;182:1191-9.
22. 22. Goodwin TM, Valenzuela GJ, Silver H, Creasy G, et al. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Obstet Gynecol 1996;88:331-6.